Poorly Differentiated Neuroendocrine Carcinoma of the Head and Neck: HPV Tumor Status / p16 Status and Impact on Overall Survival.
Poorly differentiated neuroendocrine carcinoma (PDNEC) in the head and neck is a rare high-grade neuroendocrine neoplasms. Human papillomavirus (HPV) status and p16 status are yet unclear among PDNEC owing to a lack of statistical analysis. The objective of the present study was therefore to evaluate their potential clinicopathological associations, and their prognostic impact on overall survival in PDNECs of the head and neck, regardless to subtypes of HPV. All cases of PDNEC of the head and neck between 1998 and 2019 were identified from the database of the Lyon university hospital pathology department (n=21); for these cases p16 immunohistochemistry and HPV in situ hybridization were performed. Published cases of PDNEC of the head and neck with assessment of HPV status and p16 status were identified in PubMed (n=57). Local and published cases were pooled for analysis. The HPV+ tumor status was found to be significant associated with oropharyngeal localization (p<0.001) and p16+ (p<0.001). Multivariate analysis, adjusted on tumor site, histological subtype, p16 status, HPV status and source of the case, found that oropharyngeal localization (HR:3.031, 95%CI[1.257;7.310]) and small cell variant (HR:2.859, 95%CI[1.150;7.109]) were significant predictors of a worse overall survival; HPV+ tumor status was associated with better overall survival (HR:0.388, 95%CI[0.146;0.995]). HPV+ tumor status was associated with oropharyngeal PDNECs and with better prognosis. This article is protected by copyright. All rights reserved.